Boulder, Colorado
United States
36
2025-05-15
The entities that hold a legal rights for patent applications filed by inventor Wallace Eli M.:
Eli M. Wallace from Boulder, US has applied for patents for these inventions. The list has both pending applications and granted patents:
HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS
#2 | 2022-07-21HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS
#3 | 2020-11-05HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS
#4 | 2018-06-21HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS
#5 | 2016-12-22Pyrrolopyridines as kinase inhibitors
#6 | 2016-08-18HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS
#7 | 2016-06-02HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS
#8 | 2015-11-12Pyrrolopyridines as kinase inhibitors
#9 | 2015-09-245H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors
#10 | 2015-07-09Mitotic kinesin inhibitors and methods of use thereof
#11 | 2015-03-26Substituted quinazolines as serine/threonine kinase inhibitors
#12 | 2014-11-27Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitors
#13 | 2014-11-27PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS
#14 | 2014-08-28Pyrrolopyridines as kinase inhibitors
#15 | 2014-08-07PYRROLOPYRIDINES AS KINASE INHIBITORS
#16 | 2014-04-10Pyrrolopyridines as kinase inhibitors
#17 | 2014-01-16MITOTIC KINESIN INHIBTORS AND METHODS OF USE THEREOF
#18 | 2013-04-045H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors
#19 | 2013-03-21Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
#20 | 2013-02-21Pyrrolopyridines as kinase inhibitors
#21 | 2012-09-13Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
#22 | 2011-10-135H-cyclopenta[D]pyrimidines as AKT protein kinase inhibitors
#23 | 2011-06-30Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
#24 | 2011-03-24Pyrrolopyridines as kinase inhibitors
#25 | 2011-03-03Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
#26 | 2010-12-30Mitotic kinesin inhibitors and methods of use thereof
#27 | 2010-12-23Pyrrolopyridines as kinase inhibitors
#28 | 2010-11-04Pyrazolopyridines as kinase inhibitors
#29 | 2010-10-21Method of treatment using N3 alkylated benzimidazole derivatives as MEK inhibitors
#30 | 2010-10-21N3 alkylated benzimidazole derivatives as MEK inhibitors
#31 | 2010-10-14N3 alkylated benzimidazole derivatives as MEK inhibitors
#32 | 2010-10-14N3 alkylated benzimidazole derivatives as MEK inhibitors
#33 | 2010-10-14Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
#34 | 2009-06-04Heterocyclic inhibitors of MEK and methods of use thereof
#35 | 2009-06-04Heterocyclic inhibitors of MEK and methods of use thereof
#36 | 2009-05-21Heterocyclic inhibitors of MEK and methods of use
100530 ⎘